Federal Register / Vol. 89, No. 27 / Thursday, February 8, 2024 / Notices 8691 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; FieldDeployable, Low-Cost Point-of-Need 

Approaches and Technologies to Lower the 

Barriers to Substance Use Disorders (SUD) 

Diagnosis and Treatment. 

Date: March 6, 2024. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Contact Person: Caitlin Elizabeth Angela 

Moyer, Ph.D., Scientific Review Officer, 

Scientific Review Branch, National Institute 

on Drug Abuse, NIH, 301 North Stonestreet 

Avenue, MSC 6021, Bethesda, MD 20892, 

(301) 443–4577, caitlin.moyer@nih.gov.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel; NIDA L 

Conflict SEP. 

Date: March 15, 2024. 

Time: 2:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Contact Person: Sudhirkumar Udhavrao 

Yanpallewar, M.D., Scientific Review Officer, 

Scientific Review Branch, National Institute 

on Drug Abuse, NIH, 301 North Stonestreet 

Avenue, MSC 6021, Bethesda, MD 20892, 

(301) 443–4577, sudhirkumar.yanpallewar@

nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: February 2, 2024. 

Lauren Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02526 Filed 2–7–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer Institute 

Council of Research Advocates. 

The meeting will be a hybrid meeting 

held in-person and virtually and will be 

open to the public as indicated below, 

with attendance limited to space 

available. Individuals who plan to 

attend in-person or view the virtual 

meeting and need special assistance or 

other reasonable accommodations, 

should notify the Contact Person listed 

below in advance of the meeting. The 

meeting can be accessed from the NIH 

Videocast at the following link: http:// 

videocast.nih.gov. 

Name of Committee: National Cancer 

Institute Council of Research Advocates. 

Date: March 5, 2024. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: Welcome and Chairwoman’s 

Remarks, NCI Director’s Update, NCI 

Updates, and Legislative Update. 

Place: Porter Neuroscience Research 

Center, National Institutes of Health, 

Building 35A, Room 610, 35 Convent Drive, 

Bethesda, MD 20892–2580 (Hybrid Meeting). 

Contact Person: Amy Williams, Acting 

Director, NCI Office of Advocacy Relations, 

National Cancer Institute, NIH, 31 Center 

Drive, Building 31, Room 10A28, Bethesda, 

MD 20892, (240) 781–3406, williaam@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: NCRA: http:// 

deainfo.nci.nih.gov/advisory/ncra/ncra.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 5, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02592 Filed 2–7–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Eunice Kennedy 

Shriver National Institute of Child Health 

and Human Development Special Emphasis 

Panel; HEAL Initiative: Limited Competition: 

Clinical Outcomes of Babies with Opioid 

Exposure (OBOE) Study (UG1). 

Date: March 25, 2024. 

Time: 9:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Eunice 

Kennedy Shriver National Institute of Child 

Health and Human Development, 6710B 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kimberly L. Houston, 

M.D., Scientific Review Branch, Eunice

Kennedy Shriver National Institute of Child

Health & Human Development, NIH, 6710B

Rockledge Drive, Rm. 2137C, Bethesda, MD

20892, (301) 827–4902, kimberly.houston@

nih.gov.


lotter on DSK11XQN23PROD with NOTICES1
8692 Federal Register / Vol. 89, No. 27 / Thursday, February 8, 2024 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: February 2, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02525 Filed 2–7–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket Number DHS–2024–0004] 

Agency Information Collection 

Activities: DHS Civil Rights Evaluation 

Tool, Collection Instrument DHS Form 

3095, OMB Control No. 1601–0024 

AGENCY: Department of Homeland 

Security (DHS). 

ACTION: 60-Day notice and request for 

comments; revision request. 

SUMMARY: The Department of Homeland 

Security will submit the following 

Information Collection Request (ICR) to 

the Office of Management and Budget 

(OMB) for review and clearance in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted until April 8, 2024. 

This process is conducted in accordance 

with 5 CFR 1320.1. 

ADDRESSES: You may submit comments, 

identified by docket number Docket 

#DHS–2024–0004, at: 

Æ Federal eRulemaking Portal: http:// 

www.regulations.gov. Please follow the 

instructions for submitting comments. 

Instructions: All submissions received 

must include the agency name and 

docket number Docket #DHS–2024– 

0004. All comments received will be 

posted without change to http://

www.regulations.gov, including any 

personal information provided. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http://

www.regulations.gov. 

SUPPLEMENTARY INFORMATION: Recipients 

of Federal financial assistance from the 

Department of Homeland Security 

(DHS) are required to meet certain legal 

requirements relating to 

nondiscrimination and 

nondiscriminatory use of Federal funds. 

Those requirements include ensuring 

that entities receiving Federal financial 

assistance from the DHS do not deny 

benefits or services, or otherwise 

discriminate on the basis of race, color, 

national origin, disability, age, sex, or 

religion, in accordance with the 

following authorities: 

• Title VI of the Civil Rights Act of 

1964 (Title VI) Public Law 88–352, 42 

U.S.C. 2000d–1 et seq., and the 

Department’s implementing regulation, 

6 CFR part 21 and 44 CFR part 7, which 

prohibit discrimination on the grounds 

of race, color, or national origin by 

recipients of Federal financial 

assistance. Title VI, through its 

prohibition against discrimination on 

the basis of national origin, requires 

recipients to take reasonable steps to 

provide meaningful access to persons 

who are limited English proficient 

(LEP). See Guidance to Federal 

Financial Assistance Recipients 

Regarding Title VI Prohibition Against 

National Origin Discrimination 

Affecting Limited English Proficient 

Persons, 76 FR. 21755–21768 (April 18, 

2011). 

• Section 504 of the Rehabilitation 

Act of 1973 (Section 504), Public Law 

93–112, as amended by Public Law 93– 

516, 29 U.S.C. 794, which prohibits 

discrimination on the basis of disability 

by recipients of Federal financial 

assistance. 

• Title IX of the Education 

Amendments of 1972 (title IX), 20 

U.S.C. 1681 et seq., and the 

Department’s implementing regulations, 

6 CFR part 17, and 44 CFR part 19, 

which prohibits discrimination on the 

basis of sex in education program and 

activities received Federal financial 

assistance. 

• Age Discrimination Act of 1975, 

Public Law 94–135, 42 U.S.C. 6101 et 

seq., and the Department implementing 

regulation at 44 CFR part 7, which 

prohibits discrimination on the basis of 

age by recipients of Federal financial 

assistance. 

• U.S. Department of Homeland 

Security regulation 6 CFR part 19, 

which prohibits organizations that 

receive financial assistance from DHS 

for a social service program from 

discriminating against beneficiaries on 

the basis of religion or religious belief, 

a refusal to hold a religious belief, or a 

refusal to attend or participate in a 

religious practice. 

The aforementioned civil rights 

authorities also prohibit retaliatory acts 

against individuals for participating or 

opposing discrimination in a complaint, 

investigation, or other proceeding 

related to prohibited discrimination. 

DHS has an obligation to enforce 

nondiscrimination requirements to 

ensure that its federally assisted 

programs and activities are 

administered in a nondiscriminatory 

manner. In order to carry out its 

enforcement responsibilities, DHS must 

obtain a signed assurance of compliance 

and collect and review information from 

recipients to ascertain their compliance 

with applicable requirements. DHS 

implementing regulations and the 

Department of Justice regulation 

Coordination of Non-discrimination in 

Federally Assisted Program, 28 CFR part 

42, provide for the collection of data 

and information from recipients (see 28 

CFR 42.406). 

DHS uses DHS Form 3095: DHS Civil 

Rights Evaluation Tool as the primary 

tool to implement this information 

collection. DHS is revising the 

collection, changing Section 1 of the 

form on Instructions to extend the 

deadline for initial submissions from 30 

days of receipt of the Notice of Award 

to 60 days; to update the method of 

submission from email to an online 

portal, and to make other minor 

clarifying revisions. DHS is also making 

minor changes to Section 2 of the form 

on Organization Information to remove 

the fields for reporting Grant Agreement 

Number and Federal Award 

Identification Number; DHS now 

obtains that information from 

Department data sources. In addition, 

DHS is making minor changes to 

Section 5 of the form on Additional 

Information to streamline 

communication with recipients by 

providing a single, centralized point of 

contact for questions and technical 

assistance. Further, a minor change to 

Section 2 of the form on Organization 

Information to revise the field for 

reporting the organization’s DUNS 

Number to Unique Entity ID. In 2022, 

the Federal Government stopped using 

DUNS Number to uniquely identify 

organizations and transitioned to using 

Unique Entity ID as the official 

identifier for entities doing business 

with the U.S. Government. 

DHS uses the form to collect civil 

rights related information from all 

recipients of federal financial assistance 

from the Department. Recipients are 

non-Federal entities that receive Federal 

financial assistance in the form of a 

grant, cooperative agreement, or other 

type of financial assistance directly from 

the Department and not through another 

recipient or ‘‘pass-through’’ entity. This 

information collection does not apply to 

subrecipients, Federal contractors 

(unless the contract includes the 

provision of financial assistance), nor 

the ultimate beneficiaries of services, 

financial aid, or other benefits from the 

Department. 

Recipients are required to provide the 

information 60 days from receipt of 

Notice of Award. Recipient of multiple 


lotter on DSK11XQN23PROD with NOTICES1